Literature DB >> 29416138

Spondyloarthritis: Which composite measures to use in psoriatic arthritis?

Raffaele Scarpa1, Francesco Caso1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29416138     DOI： 10.1038/nrrheum.2018.15

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment.

Authors:  L C Coates; J Fransen; P S Helliwell
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

2.  Updating the OMERACT filter at OMERACT 11.

Authors:  John R Kirwan; Maarten Boers; Peter Tugwell
Journal:  J Rheumatol       Date:  2014-05       Impact factor: 4.666

3.  Psoriatic Disease 10 Years Later.

Authors:  Raffaele Scarpa; Francesco Caso; Luisa Costa; Rosario Peluso; Antonio Del Puente; Ignazio Olivieri
Journal:  J Rheumatol       Date:  2017-09       Impact factor: 4.666

4.  Development of a preliminary composite disease activity index in psoriatic arthritis.

Authors:  Aizad Mumtaz; Phil Gallagher; Brian Kirby; Robin Waxman; Laura C Coates; Douglas Veale J; Philip Helliwell; Oliver FitzGerald
Journal:  Ann Rheum Dis       Date:  2010-11-29       Impact factor: 19.103

5.  Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis.

Authors:  Valerie P Nell-Duxneuner; Tanja A Stamm; Klaus P Machold; Stephan Pflugbeil; Daniel Aletaha; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2009-09-17       Impact factor: 19.103

6.  Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.

Authors:  Laura C Coates; Arthur Kavanaugh; Philip J Mease; Enrique R Soriano; Maria Laura Acosta-Felquer; April W Armstrong; Wilson Bautista-Molano; Wolf-Henning Boehncke; Willemina Campbell; Alberto Cauli; Luis R Espinoza; Oliver FitzGerald; Dafna D Gladman; Alice Gottlieb; Philip S Helliwell; M Elaine Husni; Thorvardur J Love; Ennio Lubrano; Neil McHugh; Peter Nash; Alexis Ogdie; Ana-Maria Orbai; Andrew Parkinson; Denis O'Sullivan; Cheryl F Rosen; Sergio Schwartzman; Evan L Siegel; Sergio Toloza; William Tuong; Christopher T Ritchlin
Journal:  Arthritis Rheumatol       Date:  2016-03-23       Impact factor: 10.995

7.  RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.

Authors:  Theodore Pincus; Christopher J Swearingen; Martin Bergman; Yusuf Yazici
Journal:  J Rheumatol       Date:  2008-09-15       Impact factor: 4.666

8.  Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.

Authors:  Laura C Coates; Oliver FitzGerald; Joseph F Merola; Josef Smolen; Leonieke J J van Mens; Heidi Bertheussen; Wolf-Henning Boehncke; Kristina Callis Duffin; Willemina Campbell; Maarten de Wit; Dafna Gladman; Alice Gottlieb; Jana James; Arthur Kavanaugh; Lars Erik Kristensen; Tore K Kvien; Thomas Luger; Neil McHugh; Philip Mease; Peter Nash; Alexis Ogdie; Cheryl F Rosen; Vibeke Strand; William Tillett; Douglas J Veale; Philip S Helliwell
Journal:  Arthritis Rheumatol       Date:  2018-02-06       Impact factor: 10.995

9.  The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project).

Authors:  Philip S Helliwell; Oliver FitzGerald; Jaap Fransen; Dafna D Gladman; Gerald G Kreuger; Kristina Callis-Duffin; Neil McHugh; Philip J Mease; Vibeke Strand; Robin Waxman; Valderilio Feijo Azevedo; Adriana Beltran Ostos; Sueli Carneiro; Alberto Cauli; Luis R Espinoza; John A Flynn; Nada Hassan; Paul Healy; Eduardo Mario Kerzberg; Yun Jong Lee; Ennio Lubrano; Antonio Marchesoni; Helena Marzo-Ortega; Giovanni Porru; Elvia G Moreta; Peter Nash; Helena Raffayova; Roberto Ranza; Siba P Raychaudhuri; Euthalia Roussou; Raphael Scarpa; Yeong Wook Song; Enrique R Soriano; Paul P Tak; Ilona Ujfalussy; Kurt de Vlam; Jessica A Walsh
Journal:  Ann Rheum Dis       Date:  2012-07-13       Impact factor: 19.103

10.  International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials.

Authors:  Ana-Maria Orbai; Maarten de Wit; Philip Mease; Judy A Shea; Laure Gossec; Ying Ying Leung; William Tillett; Musaab Elmamoun; Kristina Callis Duffin; Willemina Campbell; Robin Christensen; Laura Coates; Emma Dures; Lihi Eder; Oliver FitzGerald; Dafna Gladman; Niti Goel; Suzanne Dolwick Grieb; Sarah Hewlett; Pil Hoejgaard; Umut Kalyoncu; Chris Lindsay; Neil McHugh; Bev Shea; Ingrid Steinkoenig; Vibeke Strand; Alexis Ogdie
Journal:  Ann Rheum Dis       Date:  2016-09-09       Impact factor: 19.103
  10 in total
  2 in total

1.  Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules".

Authors:  Matteo Megna; Anna Balato; Maddalena Napolitano; Lucia Gallo; Francesco Caso; Luisa Costa; Nicola Balato; Raffaele Scarpa
Journal:  Clin Rheumatol       Date:  2018-04-11       Impact factor: 2.980

Review 2.  Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management.

Authors:  Francesco Caso; Marco Tasso; Maria Sole Chimenti; Luca Navarini; Carlo Perricone; Nicolò Girolimetto; Rosario Peluso; Antonio Del Puente; Antonella Afeltra; Roberto Perricone; Leonardo Punzi; Raffaele Scarpa; Luisa Costa
Journal:  Drugs Aging       Date:  2019-10       Impact factor: 3.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.